Haemonetics (HAE) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $121.14 +1.25%
Revenue Growth %: +5.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
LTBR, AES, SYRS, More
Revenue Growth %: +5.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.1 million versus the consensus estimate of $219.42 million.
GUIDANCE:
Haemonetics sees FY2018 EPS of $1.55-$1.65, versus the consensus of $1.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- Tower Semiconductor (TSEM) Misses Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
